Horizon Pharma USA Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $30M

Horizon Pharma USA General Information

Description

Developer of prescription drugs for mild to moderate pain relief and arthritis. The company's product candidates include a proprietary fixed dose combination formulation of NSAID and ibuprofen; and a combination oral drug product consisting of naproxen and famotidine.

Contact Information

Formerly Known As
Horizon Therapeutics Inc
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1033 Skokie Boulevard
  • Suite 355
  • Northbrook, IL 60062
  • United States
+1 (224)
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Corporate Office
  • 1033 Skokie Boulevard
  • Suite 355
  • Northbrook, IL 60062
  • United States
+1 (224)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Horizon Pharma USA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 18-Mar-2010 $30M Completed Generating Revenue
6. Later Stage VC (Series D) 18-Feb-2010 Completed Generating Revenue
5. Early Stage VC 01-Dec-2009 Completed Startup
4. Debt - General 31-Dec-2007 Completed
3. Later Stage VC (Series C) 23-Jul-2007 Completed Startup
2. Early Stage VC (Series B) 01-Nov-2006 $15M $21M Completed Startup
1. Early Stage VC (Series A) 01-Oct-2005 $6.05M $6.05M Completed Startup
To view Horizon Pharma USA’s complete valuation and funding history, request access »

Horizon Pharma USA Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series Special
Series C
Series B 1,482,213 $0.000100 $0.81 $10.12 $10.12 1x $10.12 9.01%
Series A 1,192,118 $0.000100 $0.41 $5.08 $5.08 1x $5.08 7.24%
To view Horizon Pharma USA’s complete cap table history, request access »

Horizon Pharma USA Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
EW Healthcare Partners Growth/Expansion Minority
Pequot Ventures Venture Capital Minority
Scale Venture Partners Venture Capital Minority
Sutter Hill Ventures Venture Capital Minority
To view Horizon Pharma USA’s complete investors history, request access »

Horizon Pharma USA FAQs

  • When was Horizon Pharma USA founded?

    Horizon Pharma USA was founded in 2005.

  • Where is Horizon Pharma USA headquartered?

    Horizon Pharma USA is headquartered in Northbrook, IL.

  • What industry is Horizon Pharma USA in?

    Horizon Pharma USA’s primary industry is Pharmaceuticals.

  • Is Horizon Pharma USA a private or public company?

    Horizon Pharma USA is a Private company.

  • What is Horizon Pharma USA’s current revenue?

    The current revenue for Horizon Pharma USA is .

  • How much funding has Horizon Pharma USA raised over time?

    Horizon Pharma USA has raised $129M.

  • Who are Horizon Pharma USA’s investors?

    EW Healthcare Partners, Pequot Ventures, Scale Venture Partners, and Sutter Hill Ventures have invested in Horizon Pharma USA.

  • When was Horizon Pharma USA acquired?

    Horizon Pharma USA was acquired on 18-Mar-2010.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process